Prediction of pulmonary tuberculosis treatment outcome in a sub‑Saharan African context

Journal of Public Health in Africa

 
 
Field Value
 
Title Prediction of pulmonary tuberculosis treatment outcome in a sub‑Saharan African context
 
Creator Mouafo, Joseph M.F. Yakam, André N. Simo, Claude Kamdem, Jules S. Bowong, Samuel Fono, Louis A. Noeske, Jürgen
 
Subject — scoring method; logistic regression; tuberculosis; treatment failure; Cameroon
Description Failure to treat many pathogens is a concern. Identifying a priori, patients with potential failure treatment outcome of a disease could allow measures to reduce the failure rate. The objectives of this study were to use the Scoring method to identify factors associated with the tuberculosis unsuccessful treatment outcome and to predict the treatment outcome. A total of 1,529 patients with pulmonary tuberculosis were randomly selected in the city of Douala,Cameroon, this sample was randomly split into two parts: one subsample of 1,200 patients (78%) used as the Development sample, and the remaining of 329 patients (22%) used as the Validation sample. Baseline characteristics associated with unsuccessful treatment outcomes were investigated using logistic regression. The optimal score was based on the Youden's index. HIV positive status, active smoker and non‑belief in healing were the factors significantly associated with unsuccessful treatment outcomes (P0.05). A model used to estimate the risk of unsuccessful treatment outcome was derived. The threshold probability which maximize the area under the ROC curve was 18%. Patients for whom the risk was greater than this threshold were classified as unsuccessful treatment outcome and the others as successful.HIV positive and active smoking status were associated with death; the non-belief in healing, youth and male gender associated with lost-to-follow-up, TB antecedent and not having TB contact associated with therapeutic treatment failure. To increase the tuberculosis treatment success rate, targeted follow-up could be taken during the treatment for TB patients with previous characteristics.
 
Publisher AOSIS
 
Contributor
Date 2023-10-30
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format application/pdf
Identifier 10.4081/jphia.2023.2694
 
Source Journal of Public Health in Africa; Vol 14, No 10 (2023); 9 2038-9930 2038-9922
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://publichealthinafrica.org/index.php/jphia/article/view/68/71
 
Coverage — — —
Rights Copyright (c) 2024 Joseph M.F. Mouafo, André N. Yakam, Claude Simo, Jules S. Kamdem, Samuel Bowong, Louis A. Fono, Jürgen Noeske https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT